All these researches indicated that miR-126 plays a significant role in the treatment of lung cancer through the PI3K-AKT signaling pathway, at the same time, finding a appropriate clinical drug based on the traditional applications from mechanism research has become an important method of the drug discovery. Here, AKT1 is linked to lung cancer.